对克洛沙平和精神分裂症中睡眠的元分析
Matthew R Hopkins1, Brian J Miller2
1Medical College of Georgia, Augusta University, Augusta, GA, USA.
Journal of psychopharmacology (Oxford, England)
|September 18, 2025
概括
与其他抗精神病药物相比,克洛扎治疗显著增加了精神分裂症患者白天嗜睡的风险. 需要进一步的研究,以了解睡眠变化与克洛扎的自杀风险之间的联系.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 睡眠医学 睡眠医学
背景情况:
- 克洛沙平表现出抗自杀性质,并影响睡眠.
- 睡眠障碍与增加自杀风险有关.
- 白天的昏昏欲睡和镇静是克洛扎常见的副作用.
研究的目的:
- 在随机对照试验 (RCT) 中对接受克洛扎治疗的精神分裂症患者进行系统审查和元分析.
主要方法:
- 在PubMed,PsycINFO和Web of Science数据库中搜索相关的RCT.
- 包括RCT比较克洛扎与其他精神分裂症抗精神病药物.
- 使用随机效应模型进行元分析的数据.
主要成果:
- 分析了22个涉及2991名患者的RCT (1404名克洛扎,1587名其他患者).
- 克洛扎显著增加了嗜睡的几率 (36.3%对21.9%,OR=2.06,p<0.01).
- 与 olanzapine 和 risperidone 相比,观察到睡眠率增加;剂量,年龄,性别,种族和出版年份没有关联.
结论:
- 克洛扎与睡眠率明显高于其他抗精神病药物有关.
- 需要进行进一步的研究,以了解与克洛扎治疗患者的睡眠变化和自杀风险相关的机制.
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
518
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
518
Management of Insomnia
542
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
542
Substance Use Disorders Affecting Sleep
403
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
403
Antidepressant Drugs: MAOIs and Other Agents
828
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
828
Narcolepsy
502
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
502
Psychosis: Goals of Pharmacotherapy
476
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
476


